We have built on our previous work with anti-CD117–based conditioning followed by HCT and islet transplantation to reverse diabetes in a nonautoimmune mouse model (18–20), to generate a nontoxic conditioning regimen that promotes mixed chimerism across MHC barriers in NOD mice with autoimmune diabetes. The gene discussed is KIT; the disease is diabetes mellitus.